Identity

Note
Ovarian germ cell (OGC) tumours arise in the primitive germ cells of the ovary and primarily affect younger women. Struma ovarii are the most common monodermal teratomas arising from OGCs. Struma Ovarii are characterized by a composition of at least 50% mature thyroid tissue. Two reports have shown that oncogenic mutations characteristic of thyroid carcinoma in situ, most notably mutations found in thyroid follicular cells that give rise to papillary thyroid carcinoma (PTC), can be found within the thyroid tissue of Struma Ovarii. These mutations can promote oncogenesis, resulting in initiation of PTC within the teratoma.
Clinics and pathology
Disease
Papillary thyroid carcinoma arising in struma ovarii.
Phenotype / cell stem origin
Struma ovarii originate from ovarian germ cells. Malignant transformation of these monodermal teratomas primarily occurs in follicular-like cells of the thyroid tissue contained within struma ovarii, producing a tumour that resembles papillary thyroid carcinoma.
Treatment
Surgical resection of tumour, 131 I radioablation therapy.
Cytogenetics
Cytogenetics Molecular inv(10)(q11q11)
Genes involved and proteins
Note
The inv(10)(q11q11) fuses the promoter and 5' coding regions of NCOA4 to the 3' kinase domain coding region of RET. 
RET
Result of the chromosomal anomaly
Hybrid Gene
The RET/NCOA4 fusion gene is also referred to as PTC3.
Description
The inv (10) 
Fusion Protein
The RET/NCOA4 fusion protein is also referred to as PTC3. 
To be noted
Although RET/NCOA4 fusion proteins are known to play a role in initiating papillary thyroid carcinoma, they can also occur as a late mutational event. As with all tumours, care must be taken in attributing oncogenesis to a single genetic event.
